Additionally, the US FDA has also approved Wegovy and Rybelsus to help reduce cardiovascular risks in high-risk patients who also have obesity
aims at meeting the needs of customers for innovative health and wellness solutions with its high quality products
The decision to use weight loss medications is made collaboratively, based on factors such as your body mass index (BMI), any weight-related health conditions (like type 2 diabetes, high blood pressure, or chronic pain), and your previous efforts with lifestyle changes
If it doesnt, your healthcare provider can submit an appeal on your behalf
While some healthcare professionals may prescribe semaglutide off-label or for people who dont meet the criteria above, such as for weight loss in individuals without diabetes, those prescriptions will not typically be covered by insurance